Results 61 to 70 of about 8,310 (206)

Anterolateral‐Thigh Fascia Lata Free Flap Versus Fibula Free Flap for Mandibular Osteoradionecrosis

open access: yesThe Laryngoscope, EarlyView.
The anterolateral thigh fascia lata “rescue” free flap has been employed as a novel tool in the treatment of advanced partial thickness mandibular osteoradionecrosis. Compared with the traditional fibula free flap for the same indication, the “rescue” flap provides similar outcomes in terms of disease resolution, superior functional outcomes, and ...
Conrad K. Blunck   +8 more
wiley   +1 more source

Clinical profile of individuals with bisphosphonate-related osteonecrosis of the jaw: an integrative review

open access: yesSão Paulo Medical Journal, 2020
BACKGROUND: Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is still the most prevalent type of osteonecrosis with clinical relevance. In Brazil, bisphosphonate use is high but there is a lack of epidemiological studies on BRONJ. OBJECTIVE: To
Aloizio Premoli Maciel   +4 more
doaj   +1 more source

Pathophysiology of Medication‐Related Osteonecrosis of the Jaw—A Minireview

open access: yesJBMR Plus, 2023
Medication‐related osteonecrosis of the jaw (MRONJ) is a rare but serious adverse effect of antiresorptive medications administered for control of osseous malignancy, osteoporosis, or other bone metabolic diseases.
Sotirios Tetradis   +2 more
doaj   +1 more source

Bisphosphonates and Their Influence on the Implant Failure: A Systematic Review

open access: yesApplied Sciences, 2023
Objective: The goal of this systematic review was to study the relationship between the use of bisphosphonates (oral or intravenous) and its effect on implant osseointegration. Methods: The focused question was “In patients medicated with bisphosphonates
Cristiana Gomes Rebelo   +4 more
doaj   +1 more source

Osteopathology induced by bisphosphonates and dental implants: clinical observations [PDF]

open access: yes, 2018
Objectives: Although there are many reports about risk factors for the development of BP-associated osteonecrosis of the jaws, the role of dental implants as a local risk factor is still discussed, especially in patients with oral BP treatment. Until now,
Grätz, Klaus-Wilhelm   +5 more
core  

Antiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw [PDF]

open access: yes, 2016
Antiresorptive agent-related osteonecrosis of the jaw (ARONJ) is an intractable, though rare, complication in cancer patients with bone metastases and patients with osteoporosis who are treated with antiresorptive agents, including bisphosphonates and ...
Akira Taguchi   +11 more
core   +1 more source

Soluble Sema4D From γδ T Cells Exerts Osteoblast Inhibition via Plexin‐B/mTOR Signalling Contributing to Pathogenesis of Bisphosphonate‐Related Osteonecrosis of the Jaws

open access: yesCell Proliferation, EarlyView.
Schematic summarizing the pathway of sSema4D from γδ T cells inhibiting osteoblast differentiation in BRONJ. ABSTRACT Bisphosphonate‐related osteonecrosis of the jaw (BRONJ) is a severe complication in patients undergoing long‐term bisphosphonate therapy, while our knowledge on the pathogenesis of BRONJ is far from sufficient.
Lingling Ou   +15 more
wiley   +1 more source

Fibrous Dysplasia and Medication-Related Osteonecrosis of the Jaw [PDF]

open access: yesJournal of Oral and Maxillofacial Surgery, 2016
Osteonecrosis of the jaw (ONJ) is an established side effect of intravenous bisphosphonates and other antiresorptive medications. Although bisphosphonates are frequently prescribed for patients with the skeletal disorder fibrous dysplasia (FD), there are no reports of ONJ in this population.
Tarek, Metwally   +4 more
openaire   +2 more sources

Knowledge and Attitudes of Oral Health Professionals to Different Dental Treatment Approaches in Bisphosphonate Therapy

open access: yesCurrent Research in Dental Sciences
Objective: This study evaluates oral healthcare professionals’ attitudes towards managing different dental clinical scenarios considering different durations and administration routes of antiresorptive drugs. Methods: This study is a cross-sectional, Web-
Şebnem Dirikan İpci   +4 more
doaj   +1 more source

Application Strategies of Bone Marrow Mesenchymal Stromal Cells in Bone‐Related Diseases

open access: yesCell Proliferation, EarlyView.
Engineered BMSCs and vesicles enhance therapy effects for bone diseases via multi‐strategic approaches. ABSTRACT Bone‐related diseases (e.g., osteoporosis, osteoarthritis and fractures) exhibit a rising global incidence, imposing significant burdens on both quality of life and healthcare systems.
Xuemei Long   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy